← Back
$APLS All transactions

Apellis Pharmaceuticals, Inc.

▼ SELL

$ Value

$45K

Shares

2,064

Price

$22

Filed

Jan 23

Insider

Name

Chopas James George

Title

VP/Chief Accounting Officer

CIK

0001836430

Roles

Officer

Transaction Details

Transaction Date

2026-01-22

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

49,805

Footnotes

This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 21, 2026.

Filing Info

Accession No.

0001492422-26-000060

Form Type

4

Issuer CIK

0001492422

Chopas James George's History

Date Ticker Type Value
2026-01-28 APLS A $0
2026-01-22 APLS $45K
2026-01-20 APLS $14K
2026-01-13 APLS $19K
2025-09-15 APLS $5K
2025-09-02 APLS $15K
2025-06-18 APLS A $0
2025-06-09 APLS A $218K

Other Insiders at APLS (90d)

Insider Bought Sold Last
Dolsten Mikael 2026-02-27
Watson David O.
General Counsel
2026-01-28
Deschatelets Pascal
Chief Scientific Officer
2026-01-28
Francois Cedric
Chief Executive Officer
2026-03-11
Sullivan Timothy Eugene
Chief Financial Officer
2026-04-17
O'Brien Stephanie Monaghan 2026-04-06
Nicholson Nur
Chief Technical Officer
2026-01-28
Chopas James George
VP/Chief Accounting Officer
2026-01-28
DeLong Mark Jeffrey
Chief Business & Strat Officer
$8K 2026-02-11
Boucher Kelley
Chief People Officer
2026-01-28
MELTZER LESLIE
Chief Research and Development
2026-01-28